Infants and Children Under 12 Given the Pfizer mRNA COVID “Vaccine” Seven Months BEFORE Pediatric Approval. 71% Suffered Serious Adverse Events.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) produced a shocking review of the pediatric data found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Important points from this report include Of the 34 cases, 24 (71%) were classified as serious Predominantly female patients were affected - at least 25 of 34 (73.5%) patients Table 6 reports 34 cases of use in pediatric individuals 28 additional cases were excluded because details such as height and weight were not consistent with pediatric subjects The Results It is important to note 1) that the adverse events in the 5.3.6 document were reported to Pfizer for only a 90-day period starting on December 1, 2020, the date of the United Kingdom's public rollout of Pfizer's COVID-19 experimental mRNA "Vaccine" product and 2) no pediatric dose of the Pfizer product was approved for use during that time frame. What do...